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TESTICULAR GERM CELL TLMORS
As reviewed in Chapter L, testicular germ cell tumors can be divided into
seminomas, composed of neoplastic gonocytes, and nonseminomas, pluripotent tumors which
can be considered as the neoplastic counterpart of early embryos. The germ cell origin of
these tumors is firmly established, and current concepts consider intratubular germ cell
neoplasia as the preinvasive stage of all adult testicular germ cell tumors with the possible
exception of spermatocytic seminoma. Evidence is emerging that seminomas and
nonseminomas are histogenetically related and represent stages in tumor progression of
testicular germ cell tumors. Progression of intratubular genn cell neoplasia to seminoma
and/or nonseminoma is accompanied by significant changes in ploidy and karyotype. The
inherent aggressiveness of the histological subtypes largely determines the heterogeneity of
testicular germ cell tumors with respect to clinical presentation and reaction to therapy. Yet,
(epigenetic) factors that control phenotypic expression, and thus the biology of the
histological subtypes, are largely undefined. The choice of therapy in testicular germ cell
fumors depends on the histology of the primary tumor (seminoma versus nonseminoma),
clinical stage, and the anticipated biological stage. The latter may be extrapolated from
clinical, pathological, biological, and genetic parameters. Although testicular germ cell
tumors have become a model for curable cancer, presently about 20% of all patients with a
testicular germ cell malignancy will succumb due to the growth of residual tumor resistant
to chemotherapeutic drugs.
INTEGRINS AND EXTRACELLI.]LAR MATRIX PROTEINS IN THE BIOLOGY OF
TESTICULAR GERM CELL TLMORS
Normal testis and testis with intratubular germ cell neoplasia
In Paragraph 2.1.2 a review is given on the presence and function of extracellular
matrix (ECM) proteins in the developing and mature testis. Similar to morphogenetic
processes in other organ systems it appears that ECM proteins play a pivotal role in testicular
development. For example, the selective distribution of fibronectin along the migration
pathway of primordial germ cells suggests that migration of primordial germ cells is at least
in part dependent on their interaction with fibronectin. The onset of testicular cord formation
is associated with marked changes in the distribution of ECM proteins. However, presently
it is not yet clear whether cell-matrix interactions provide the initial signal that activates the
morphogenetic cascade or whether initially soluble factors are involved. The coordinated
interaction of both myoid cells and Sertoli cells is essential for the formation of the basement
membrane (BM) that surrounds testicular cords and, later on, the seminiferous tubules.
Conversely, in the adult testis normal seminiferous tubule function including spermatogenesis
seems to be dependent on the cooperative action of Sertoli and myoid cells, in which the
tubular BM plays a essential role. In atrophic tubules and in intratubular germ cell neoplasia
the lamina propria and tubular BM were thickened with invaginations of the BM into the
tubular lumen (Chapter 2.2). This increase in the deposition of ECM proteins suggest that
the balance between production and degradation of BM constituents is lost, either by
increased deposition or by decreased degradation of BM components. Yet, at this moment
it is impossible to determine whether the impaired spermatogenesis is the trigger that leads
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to increased deposition of ECM proteins or that the impaired spermatogenesis is secondary
to the changes that occur in the tubular BM. In tubules containing intratubular germ cell
neoplasia these changes may be related to a disregulation of testicular homeostasis, rather
than to the presence of malignant intratubular germ cells per se, as similar abnormalities are
observed in a variety of local and systemic pathological conditions that lead to tubular
atrophy and hyalinization. Finally, in tubules with impaired spermatogenesis, Sertoli cells
have been described to coexpress vimentin and keratin r, a feature that is characteristic for
immafure prepuberal Sertoli cells 2. By comparing the integrin profile of foetal and
prepuberal Sertoli cells with Sertoli cells in atrophic and intratubular germ cell neoplasia
containing tubules, one might elucidate whether increased expression of a3 and cu6 integrin
subunits on Sertoli cells in these abnormal tubules is a sign of immaturity.
Integrins in the biology of malignant tumors
The role of the integrin-matrix interactions in the biology of malignant tumors in
general is discussed in Paragraph 2.1.3. Upon malignant transformation and subsequent
tumor progression the pattern of integrin expression changes and becomes disorganized.
However, lineage specific integrin distribution patterns may be conserved in malignant
tumors, and occasionally reexpression of embryonal integrins may be observed. Compared
to their nonfumorigenic counterparts malignant tumors in general show a tendency to express
reduced levels of integrins, although in some tumors integrins may be upregulated, or
expressed de novo. Functionally, integrins may have inhibitory as well stimulatory effects
on tumor cell growth, that in part may be related to conferral of resistance to anoikis
(apoptotic cell response after detachment of cells from the ECM) or rescue from programmed
cell death by ECM-mediated ligation of integrins present on the tumor cell surface.
Furthermore, integrins may inhibit as well as promote the formation of metastases, and can
play different roles at different metastatic stages. In line with current concepts on metastasis
formation it appears that the effects of integrins on tumor growth and metastasis formation
are not necessarily linked. Thus, although the redundancy in integrin-ligand interactions is
enonnous, experimental data point to different roles for specific integrins at different stages
of the metastatic cascade. The association of specific integrin subunits with grade, stage,
disease-free survival and overall-survival supports the view that integrins may be used as
biological parameters that aid in the evaluation of the risk for metastasis formation and the
choice of adequate therapy.
Seminoma
Data on the expression of integrin subunits and distribution of ECM proteins in
intratubular germ cell neoplasia, seminoma and nonseminoma (Chapters 2.2 and 2.3) are
concordant with data reviewed in Paragraph 2.1.3. Malignant intratubular germ cells showed
a strong, nonpolarized expression of the cu3, and cr6 integrin subunits, and a weak expression
of the 81 integrin subunit. Progression of intratubular genn cell neoplasia to invasive
seminoma was associated with loss of c3 integrin subunit expression. In primary seminomas
the o5 integrin subunit was weakly expressed in all stages. All tumors showed a strong
expression of o6 and 01 integrin subunits. Compatible withdegradation of BM components,
in intratubular gerrn cell neoplasia the tubular BM revealed gaps besides thickened and
irregular parts. Based on the distribution of collagen type I, 3 types of stromal reaction could
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be recognized. Since differences between the three types of stromal reaction were partly
relative, they may represent different stages in the ongoing process of fibrovascular stroma
formation. Small band-like structures resembling BMs were randomly distributed in all
primary seminomas and metastases of primary seminomas. These structures may well
represent tubular remnants, not degradated by proteolytic enzymes. However, the linear
distribution of BM components at the interface of tumor cells and stroma, and the presence
of these structures in metastatic lesions suggests that BM components in seminomas may also
be newly deposited.
The heterogeneity in integrin subunit expression and distribution of ECM proteins
suggest a dynamic interplay between seminoma cells and host cells. However, the
contribution of both cell populations to the formation of the ECM has to determined. It seems
likely that seminoma cells themselves do not contribute significantly to the formation of the
ECM as cytoplasmic staining for ECM proteins is not evident (unpublished observations, r).
Whatever the origin of the ECM in seminomas, the interaction of seminoma cells with the
microenvironment is likely to interfere with processes such as cell survival, proliferation, and
migration. The observation that seminoma cells enter an apoptotic pathway, when kept in
vitro in the absence of a specific matrix a, is in line with this hypothesis, and future studies
will have to elucidate whether this response can be viewed as anoikis. In contrast to the
former, integrin-matrix interactions may also have an adverse effect on the invasiveness and
metastatic competence of seminoma cells. Experimental studies suggest that the adhesiveness
of primordial germ cells to fibronectin in part determines the motility of these cells. E.g.,
the switch from nonmigratory to migratory stages of primordial germ cell migration coincides
with a decreased adhesion of primordial germ cells to fibronectin (Paragraph 2.1.I).
Similarly, and analogous to the adhesion of intratubular cells to the tubular BM, adhesion of
seminoma cells to BM-like structures and the interstitial matrix may hamper their migration
and bear on the development of metastases. Interestingly, malignant intratubular germ cells
and invasive seminomas express the same integrins (o3, a5, a6, and 81) as nonmigratory
murine primordial germ cells. As primordial germ cell migration is a highly conserved
process in different species (Paragraph 2.1.1) one might speculate that human primordial
germ cells use the same set of integrins as their murine counterparts. Future studies will have
to elucidate whether the (adhesive) mechanisms used by malignant intratubular germ cells and
seminoma cells to survive, proliferate and migrate, are analogous to the ones used by their
nontumorigenic precursors and counterparts, e.g., human primordial germ cells and
gonocytes respectively. Of special interest is the role of c-kit-stem cell factor interactions as
c-kit is expressed by human primordial germ cells as well as malignant intratubular germ
cells and seminoma cells 5'6, and has been shown to modulate the (integrin-mediated)
adhesiveness of hematopoietic cells to substrates coated with ECM proteins 7'8. Similarly, one
might speculate that binding of stem cell factor to c-kit on malignant intratubular germ cells
and seminoma cells may modulate the expression and function of integrins on the tumor cell
surface.
Nonseminoma
In Chapter 2.3 results are presented on the expression of integrin subunits and
distribution of ECM proteins in 34 testicular nonseminomas. In line with the epithelial nature
of embryonal carcinoma cells are the weak expression of epithelial a2 and o3 integrin
subunits, and the variable increased density of the o6 integrin subunit at the interface of
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tumor cells and the stroma. Putatively, embryonal carcinomas with features of ongoing
epithelial differentiation may behave differently, e.g., are associated with less malignant
properties. Support for this case can be found from studies in which testicular germ cell
tumors with an inherent capacity for somatic differentiation, apparent from a teratoma
component, are associated with a better prognosis (Chapter 1). In contrast to highly invasive
embryonal carcinoma, mature teratomas are supposed to be noninvasive and nonmetastatic.
Concordantly, mature teratomas are composed of a variety of highly differentiated tissues
derived from all three germ layers. Despite this benign phenotype, teratomas are in fact
malignant as illustrated by the presence of marked genetic abnormalities, and the ability of
residual mature teratoma to grow and progress to a non-germ cell malignancy (Chapter 1).
Similar to their nonneoplastic counterparts, in teratoma each tissue has its own characteristic
integrin profile, suggesting that in teratoma conserved presence of integrins may contribute
to the high degree of differentiation and in this way to the indolent biological behavior of this
histological subtype. Like teratomas, yolk sac tumors may also be composed of different
histological subtypes e. Yet, in our study the number of yolk sac tumors was to limited to
draw conclusions on the relation of integrin subunit expression and histological subtype. In
choriocarcinomas syncytiotrophoblastic giant cells as well as cytotrophoblastic cells
demonstrated a complex integrin phenotype. Most of the integrin subunits were shared by
both cell types, although differences in staining intensity were observed. Compared to normal
placental cytotrophoblastic cells, in choriocarcinoma cytotrophoblastic cells showed aberrant
expression of integrin subunits, putatively leading to a disbalance between cell-matrix
interactions that promote invasion (collager/laminin-cv1B1 integrin interactions) and those that
restrain invasion (fibronectin-o5B1 interactions) of normal cytotrophoblastic cells. The
differences in distribution of ECM proteins between the different histological subtypes were
relative. Variable in vitro synthesis of ECM proteins by different histological subtypes
suggests an in part lineage dependent tumor cell origin of ECM proteins in vivo r0-r3.
Investigation of ECM protein isoform distribution, for example by using antibodies directed
against the different chains of the laminin molecule ra, D?y reveal in addition to quantitative
differences, qualitative differences in distribution of ECM proteins, that can be expected to
be relevant to the biology of these tumors rs'16. Interestingly, in vitro growth of embryonal
carcinoma cells can be supported by ECM proteins secreted by yolk sac tumors 12. Similarly,
and analogous to paracrine support of neighboring cells during the early stages of
embryogenesis tt one might hypothesize that paracrine support of one particular germ cell
tumor to another is relevant to the biology of testicular germ cell tumors as well.
Of particular interest is the remaining question how differentiation in testicular germ
cell tumors is regulated. Based on several studies, a prominent role for genetic factors can
be recognized as several tumor suppressor genes and oncogenes show a histological subtype
restricted expression pattern, that may be determined by tumor progression related loss or
gain of genes essential to growth and differentiation 17'18. The imprinting status of the genome
in testicular germ cell tumors is supposed to be dependent on the maturation stage of the
primordial germ cell at the time of initiation. In fact, by regulating which part of the genome
will be transcribed, genomic imprinting may determine whether in testicular germ cell tumors
differentiation proceeds along the germinal, embryonal, or extraembryonal lineage (Chapter
1). The extensive differentiation of human embryonal carcinoma cells after subcutaneous
injection of nude mice (Chapters 4.1 and 4.2), and the derivation of distinct cell types upon
application of different differentiation inducers re'20 suggest that the phenotype of human
testicular germ cell tumors is dependent on the cooperative action of multiple factors present
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in the microenvironment. Indeed, the heterogeneity of testicular germ cell tumors with
respect to integrin subunit expression suggests that cell-matrix interactions are involved in
differentiation of these tumors. Yet, whether integrins contribute actively to differentiation
by inducing and/or repressing histological subtype specific gene expression (outside-in
signalling), or whether expression of integrins is a reflection of the process of differentiation
itself (inside-out signalling) is to be determined. In a recent study, morphological
differentiation of murine F9 embryonal carcinoma cells was shown to be prevented by
abrogation of Bl integrin-ECM interactions 2r. Analogously, one might hypothesize that the
morphological changes that coincide with tumor progression of intratubular genn neoplasia
to invasive nonseminoma are integrin mediated as well. Obviously, to confirm this
hypothesis, seminoma cell lines are needed in which seminoma cells can be reprogrammed
to pluripotency. Besides cell-matrix interactions other epigenetic factors may contribute to
testicular germ cell tumor differentiation. Among these growth factors/cytokines, hormones,
vitamins, and cell-cell interactions can be considered to be the most important. Intratumoral
variation of these factors, and of metabolic substrates, PH and oxygenation, gives a selective
pressure that may lead to heterogeneity, and further contributes to differentiation of these
fumors 22-24.
In conclusion, the developmental potential of testicular germ cell tumors seems to be
restricted by the (tumor progression related) genetic make up of the tumor and the imprinting
status of the genome. Yet, to express the differentiated phenotype microenvironmental factors
are needed. This regulatory model assumes that differentiation in testicular germ cell fumors
is highly regulated, and therefore susceptible to the differentiation inducing activity of agents
like retinoids.
DIFFERENTIATION INDUCTION AS PART OF ANTI-CANCER THERAPY IN
MURINE AND HUMAN TERATOCARCINOMAS
A major challenge in the treatment of patients with testicular germ cell tumors is the
cure of patients with tumors that are inherently resistant or have become resistant to
chemotherapeutic drugs. Salvage therapies have been developed and are under investigation.
At the worst still 20% of patients with advanced nonseminomas can not be cured. Potentially
retinoids might play a role in better treatment results in these groups. Combination of
chemotherapy and induction of (terminal) differentiation by means of retinoids might
theoretically be fruitful as the mechanisms of action are quite different: tumor cell kill and
in addition reversion of malignant phenotype of (chemotherapy resistant) tumor cells into
terminally differentiated nonproliferating, noninvasive cells.
Murine teratocarcinoma
In Chapter 3 the combination of a cytotoxic drug and a differentiation inducing agent
in vivo in three murine teratocarcinoma models with different levels of spontaneous somatic
differentiation (886-379 (moderate differentiation); NF-1 (poor differentiation); MH-15 (no
differentiation)) is discussed. Cisdiamminedichloroplatinum(Il) (CDDP) was used as a
cytotoxic drug and all-trans retinoic acid was used as differentiation inducing agent. The




of all-trans retinoic acid and CDDP gave a significant further reduction of tumor size as
compared with either all-trans retinoic acid or CDDP alone. All-trans retinoic acid as
differentiation inducing agent increased the percentage of differentiated residual tissue, but
only in tumors with the capacity of spontaneous omatic differentiation (NF-1 and E86-379).
The nullipotent MH-15 tumor was not induced to differentiate, and thus did not give rise to
residual mature teratoma. Rather than having an adverse effect, it turned out that all-trans
retinoic acid alone tended to reduce tumor growth in all models, however, only significant
reduction was found in the MH-l5 tumors. This indicates that, similar to the effect of 13-cis
retinoic in xenografts of Tera-CP (Chapter 4.2), the effect of all-trans retinoic acid in MH-15
tumors probably was more a result of retinoid-induced growth inhibition than a effect of
induction of differentiation. Thus, in murine teratocarcinomas the use of all-trans retinoic
acid as a differentiation inducing agent indeed increases the percentage of differentiated
residual tumor, but only in tumors with the capacity of spontaneous somatic differentiation.
Human teratocarcinoma
Acquired resistance to CDDP is one of the major problems encountered in the therapy
of testicular germ cell tumors. The mechanisms contributing to CDDP resistance are diverse,
and include reduced drug accumulation and increased detoxification in the cytoplasm. In the
cell nucleus, decreased DNA accessibility and DNA repair may play a role2s'26. Chapter 4.1
describes a 3.7 fold CDDP-resistant subline (Tera-CP) of NTera/2Dl (Tera), an human
embryonal carcinoma cell line with the capacity to differentiate in vitro as well as in vivo.
In vitro both cell lines mainly consisted of embryonal carcinoma cells. For this reason, in
Tera-CP CDDP-resistance seems not to be due to a selection of somatically differentiated
cells, as is observed in residual lesions of patients treated for a testicular nonseminoma with
an inherent capacity for somatic differentiation apparent from a teratoma component (Chapter
1). Tera-CP showed an l.4-fold increased glutathione (GSH) level, a l.5-fold increased
glutathione S-transferase (GST) activity, and a 1.4-fold increased GST-z expression
compared to Tera. The decreased binding of CDDP to DNA in Tera-CP may, in the absence
of accumulation defects and in the presence of normal activity of DNA repair enzymes
(thymidilate synthase, topoisomerase I and II) be due to an increased efficiency of the
detoxifying system. Based on the response of Tera and Tera-CP to a single intraperitoneal
dose of 5 mg/kg body weight, an in vivo resistance factor of 2.8 could be calculated. In new
cell lines derived from xenografts of Tera and Tera-CP, CDDP sensitivity, GST activity and
GSH level corresponded with their sensitivity and resistant origin. Thus, Tera-CP is a model
of in vitro and in vivo CDDP resistance with the GSH/GST detoxifying system as an
important mechanism. The close correlation of in vitro and in vivo degree of resistance
excludes a role for in vivo active, tumor associated factors that influence the
pharmacokinetics of CDDP in this nude mouse model, a phenomenon described for a model
with in vivo acquired resistance 27. Generally, in vitro selection of sublines resistant to
chemotherapeutic drugs is accompanied by a decrease in malignant potential, and this
phenomenon is referred to as "reverse transformation" 28. However, compared to the CDDP
sensitive parental cell line Tera, the CDDP-resistant subline Tera-CP demonstrated an
increased tumorigenicity (Chapter 4.2). Although in vitro both cell lines showed the same
propensity to differentiate 2e, in vivo the percentage of differentiated tissue in Tera is higher
than in Tera-CP, and this difference may explain at least in part the increased tumorigenicity
of Tera-CP cells.
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In Chapter 4.2 data are presented on the potential of the combination of a
differentiation inducing agent and CDDP treatment, in comparison to each drug alone in
xenografts derived from Tera and Tera-CP. Based on the more favorable in vivo
pharmacokinetics and the expectation of biologically comparable results, in the presenr srudy
13-cis retinoic acid was used as a differentiation inducing agent instead of all-trans retinoic
acid. CDDP sensitivity of tumor cells in vivo was not negatively influenced by (pre)treatment
with 13-cis retinoic acid. Neither in Tera nor in Tera-CP an increased tumor reduction could
be observed in mice treated with CDDP followed by 13-cis retinoic acid compared to the
mice treated with CDDP alone. This was in contrast with in vivo potentiation of CDDP
cytotoxicity by all-trans retinoic acid in tumors of murine embryonal carcinoma cells with
an inherent capacity to differentiate (Chapter 3). This discrepancy could not be due to a
complete lack of 13-cis retinoic acid-effect, as in the Tera-CP tumors with only 13-cis
retinoic acid a tumor reduction of 20% was achieved. Analogous to the development of
clinically favorable residual mature teratoma after chemotherapy for testicular germ cell
rumors with an inherent capacity for somatic differentiation (Chapter l), in the CDDP
sensitive Tera tumors with the more extensive differentiation, differentiated cells with
inherent resistance to CDDP seemed to survive treatment selectively. In the Tera-CP tumors
with acquired CDDP resistance, with less spontaneous somatic differentiation, not only
differentiated cells but also embryonal carcinoma cells were present after treatment. The
latter gave rise to regrowth of the tumor. Thus, residual lesions of Tera and Tera-CP tumors
after treatment with CDDP showed similarities to inherent (CDDP resistant somatically
differentiated tumor cells) and acquired CDDP resistance (CDDP resistant undifferentiated
embryonal carcinoma cells), as is encountered in the clinical situation. In Tera-CP, addition
of 13-cis retinoic acid to CDDP treatment increased differentiation of post-therapy residual
tumor cells, thus reducing the invasiveness and metastatic competence of this tumor residue.
However, in Tera and Tera-CP differentiation was incomplete and immature. As in vitro
embryonal carcinoma cells can be induced to differentiate terminally into nonmitotic neuronal
cells 30, one might speculate that the treatment schedule used in our experiment was
inappropriate. In order to improve antitumor activity, simultaneous administration of 13-cis
retinoic acid and CDDP should be considered for future studies. Regrowth of murine
teratocarcinomas after the dose reduction of CDDP (Chapter 3), and the inability of 13-cis
retinoic acid to preyent regrowth of Tera-CP tumors when the effect of CDDP had vanished
are further arguments for simultaneous administration of CDDP and 13-cis retinoic acid.
Finally, enhancement ofthe effect of 13-cis retinoic acid can be reached by adding cytokines,
or other biological response modifiers to the treatment regimen 3r'32. Future studies will have
to reveal if these alternatives increase the response of embryonal carcinoma cells to retinoids.
Finally, our recent data differ from earlier results 2e, as in vitro pretreatment of Tera and
Tera-CP with all-trans retinoic acid (and 13-cis retinoic acid, H. Timmer-Bosscha, personal
communication) for 96 hours strongly prevented cytotoxicity induced by CDDP. Apparently,
the response of both cell lines to retinoids is modulated by the microenvironment in which
embryonal carcinoma cells reside.
The expression of many genes is altered after treatment with retinoids. Among these
are genes that encode proteins that play a role in cell-matrix interactions (Chapter 1). In
Chapter 4.3 the expression of integrin (subunits) in the human embryonal carcinoma cell line
Tera and its 3.7 fold CDDP resistant subline Tera-CP is discussed before and after treatment
with 10 7M all-trans retinoic acid for 96 hours. The ol and o3 inteqrin subunits were weakly
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expressed in less than 5% of the tumor cells. Both cell lines showed uniform expression of
a5, a6, cyv, and 81 integrin subunits. The ovB5 integrin was expressed by nearly all tumor
cells. Neither in Tera nor in Tera-CP a2, a4,83, and 84 integrin subunits could be detected.
Although integrins expressed by Tera and Tera-CP are likely to play an active role in growth
and differentiation, it is difficult to discern whether expression of integrin subunits simply
is a tissue culture induced phenomenon, or alternatively reflects the degree of malignancy of
the cell, and could be related to the degree and lineage of differentiation. No differences were
observed in integrin (subunit) expression that might account for differences in growth and
differentiation observed in vivo (Chapter 4.2). Moreover, it seems likely that integrins do not
play a major role in cell functions operational in resistance to CDDP. However, the extensive
differentiation observed in xenografts of Tera as well Tera-CP (Chapters 4.1 and 4.2)
suggests that differentiation in both cell lines is dependent on multiple factors, present in the
microenvironment. Hypothetically, the dissimilarity in genetic make up between Tera and
Tera-CP may result in differences in cellular signal transduction pathways that only becomes
apparent after engagement of the proper microenvironment. Upon application of all-trans
retinoic acid the cv4 integrin subunit was expressed de novo in less than 5% of the fumor
cells, whereas increased staining intensity was noticed for the o5 integrin subunit, suggesting
that in Tera and Tera-CP all-trans retinoic acid may exert its action by modulation of cell-
matrix interactions. In vitro pretreatment of murine F9 embryonal carcinoma cells with all-
trans retinoic acid resulted in a decreased tumorigenicity and a different pattern of metastasis
formation of tail vein injected tumor cells 33, that at least in part may depend on modulation
of the growth response of tumor cells to the local microenvironment, and changes in the (81
integrin mediated) adhesiveness of tumor cells 3a'35. Future studies will have to elucidate
whether, similar to the effects of all-trans retinoic acid on murine F9 embryonal carcinoma
cells, in Tera and Tera-CP retinoid-induced changes in integrin expression are related directly
to modulation of growth, invasiveness, and metastatic competence of tumor cells.
CONCLUSIONS AND FUTURE PROSPECTS
It is conceivable to assume that parallels can be drawn between tumors cells and their
nonneoplastic counterparts, as tumors can be considered as caricatures of normal tissue
renewal and early embryogenesis 36'37. Concordantly, compared to their nonneoplastic
counterparts, in testicular germ cell tumors a partially conserved expression of integrin
subunits was noticed, suggestive to be related to differentiation lineage and biological
behavior (Chapters 2.2 arfl 2.3). However, processes such as invasion and development of
metastases are highly regulated, and multiple factors are likely to contribute to the
invasiveness and metastatic competence of tumor cells. The disregulation of multiple
regulatory mechanisms operative during physiological processes determines the
aggressiveness of a tumor 38'3e. From this point of view, the role of integrins in the biology
of testicular germ cell tumors can only be fully understood if the relation between integrin-
dependent and nonintegrin-dependent signal transduction pathways is elucidated.
In order to grow, invade, and metastasize, tumor cells have to elicit their own
microenvironment or must become, to a certain degree, independent from their specific
microenvironment. In agreement with this, in testicular germ cell tumors ECM protein
distribution was heterogeneous, and suggestive to be related to the biology of seminomas as
well as nonseminomas. However, the mechanisms responsible for this heterogeneity have to
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